Roche sets sights on FDA approval decision of July 2027 with updated eye drug data
Roche sets sights on FDA approval decision of July 2027 with updated eye drug data Fierce Biotech
Regulatory Approvals
FDA Clears Phase 2 Trial of B7-H3 CAR T MT027 for Brain Metastases
FDA Clears Phase 2 Trial of B7-H3 CAR T MT027 for Brain Metastases Targeted Oncology
FDA Approves Once-Monthly Olanzapine Injection for Adults with Schizophrenia
FDA Approves Once-Monthly Olanzapine Injection for Adults with Schizophrenia Drug Topics
FDA approves Hovilpri for treating herpes lesions
FDA approves Hovilpri for treating herpes lesions Outbreak News Today
FDA Grants Accelerated Approval to a New Breast Cancer Treatment
The U.S. Food and Drug Administration today expanded treatment options for adult patients with advanced breast cancer, reflecting the FDA’s…